Wine in moderation reduces mortality

The analysis of 11,000 patients in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified-Release Controlled Evaluation (ADVANCE) trial compared abstinence with moderate and heavy drinking over five years.

It showed moderate alcohol consumption (<15 drinks per week for women and <20 for men) reduced CV events by 17%, microvascular complications by 15% and all-cause mortality by 13%.

The benefits of alcohol were particularly evident in people who drank mainly